Kanaka Probiotics: KABP-051 and the future of weight management and psychobiotics
10 Jul 2026 | Kaneka Probiotics
Kaneka Probiotics and AB-Biotics’ latest clinical research on probiotic Lactiplantibacillus plantarum KABP-051 observed modest weight loss alongside improvements mood and energy over 12 weeks, without a diet or exercise plan. Jordi Riera, chief business officer at Kaneka Probiotics, reveals further study details while explaining what a microbiome-based approach means for the future of psychobiotics.
Subscribe to our newsletters
By continuing to browse our site you agree to our Privacy Statement
















